Data suggest the incidence of in situ breast cancer has decreased since 2009, consistent with decreasing use of mammography in association with the 2009 USPSTF guideline change.
Male AYA cancer survivors “experience many challenges related to fertility and reproductive health,” according to researchers.
The results of this first phase 2 study of belzutifan combined with cabozantinib suggest that dual targeting of HIF-2α and VEGF pathways might be an effective first-line treatment strategy in advanced ...
For the fifth consecutive year, Congress has adjourned and allowed Medicare cuts,” said Bruce A. Scott, MD, president of the AMA.
The federal Consumer Financial Protection Bureau has issued new regulations barring medical debts from American credit reports.
Researchers noted that the safety and effectiveness of standard therapies for Merkel cell carcinoma “remains poorly studied.” ...
GSK5764227 (HS-20093) is a novel antibody-drug conjugate composed of a fully human anti-B7-H3 monoclonal antibody covalently linked to a topoisomerase inhibitor payload.
Researchers found that robotic-assisted surgery, laparoscopic surgery, and vaginal surgery produced similar outcomes in patients who were 85 years of age or older.
The researchers also projected that newly diagnosed MM cases will increase by 70.8% by 2045 — from about 188,000 cases in 2022 to about 321,000 cases in 2045. The number of deaths due to MM is ...
A study of more than 3000 physician practices revealed an increase in social risk screening from 2017 to 2022.
Young patients with low-risk, relapsed Hodgkin lymphoma may be able to avoid transplant, data from 3 studies suggest.
This page includes links to articles highlighting the top breast cancer research published on Cancer Therapy Advisor in 2024.